Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Polymorphic Variation in Glutathione-S-transferase Genes and Risk of Chronic Myeloid Leukaemia in the Kashmiri Population

  • Bhat, Gulzar (Department of Biochemistry, University of Kashmir) ;
  • Bhat, Ashaqullah (Department of Biochemistry, University of Kashmir) ;
  • Wani, Aadil (Department of Biochemistry, University of Kashmir) ;
  • Sadiq, Nida (Department of Biochemistry, University of Kashmir) ;
  • Jeelani, Samoon (Department of Clinical Hematology, SKIMS) ;
  • Kaur, Rajinder (Department of Human Biology, Punjabi University) ;
  • Masood, Akbar (Department of Biochemistry, University of Kashmir) ;
  • Ganai, Bashir (Department of Biochemistry, University of Kashmir)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Cancer is a complex disease and the genetic susceptibility to it could be an outcome of the inherited difference in the capacity of xenobiotic metabolizing enzymes. Glutathione-S-transferases (GSTs) are phase II metabolizing enzymes whose various genotypes have been associated with increased risk of different types of cancer. Null mutations caused by the deletion of the entire gene result in the absence of the enzymatic activity and increase in the risk of developing cancer including chronic myeloid leukaemia (CML). In the present case-control study we evaluated the effect of null mutations in GSTM1 and GSTT1 genes on the risk of developing CML. The study included 75 CML patients (43 males and 32 females; age (mean ${\pm}$ S.D) $42.3{\pm}13.4$ years) and unrelated non-malignant controls (76 male and 48 females; age (mean ${\pm}$ S.D) $41.5{\pm}12.9$). The distribution of GSTM1 and GSTT1 genotypes in CML patients and controls was assessed by multiplex-PCR method. Logistic regression was used to assess the relationship between GSTM1 and GSTT1 genotypes and risk of CML. Chi-square test was used to evaluate the trend in modulating the risk to CML by one or more potential high risk genotype. Although GSTM1 null genotype frequency was higher in CML patients (41%) than in the controls (35%), it did not reached a statistical significance (OD = 1.32, 95% CI: 0.73-2.40; P value = 0.4295). The frequency of GSTT1 null genotypes was higher in the CML patients (36%) than in the controls (21%) and the difference was found to be statistically significant (OD = 2.12, 95% CI: 1.12-4.02; P value = 0.0308). This suggests that the presence of GSTT1genotype may have protective role against the CML. We found a statistically significant (OD = 3.09, 95% CI: 1.122-8.528; P value = 0.0472) interaction between the GSTM1 and GSTT1 null genotypes and thus individuals carrying null genotypes of both GSTM1 and GSTT1 genes are at elevated risk of CML.

Keywords

References

  1. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E (2004). CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet. Cytogenet, 154, 81-5. https://doi.org/10.1016/j.cancergencyto.2004.01.023
  2. Arand M, Mühlbauer R, Hengstler J, et al (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem, 236, 184-6. https://doi.org/10.1006/abio.1996.0153
  3. Autrup H (2000). Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res, 464, 65-76. https://doi.org/10.1016/S1383-5718(99)00167-9
  4. Bajpai P, Tripathi AK, Agrawal D (2007). Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk. Res, 31, 1359-63. https://doi.org/10.1016/j.leukres.2007.02.003
  5. Cai L, Yu SZ, Zhang ZF (2001). Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol, 7, 5060-9.
  6. Canalle R, Burim RV, Tone LG, Takahashi CS (2004). Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen, 43, 100-9. https://doi.org/10.1002/em.20003
  7. Chen H C, Hu W X, Liu Q X, et al (2008). Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev, 17, 251-8. https://doi.org/10.1097/CEJ.0b013e3282b72093
  8. Deininger MW, Goldman JM, Melo JV (2000). The molecular biology of chronic myeloid leukemia. Blood, 96, 3343-56.
  9. Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM(1999). The biology of chronic myeloid leukemia. N Engl J Med, 341, 164-72. https://doi.org/10.1056/NEJM199907153410306
  10. Garte S, Taioli E, Crosti F, et al (2000). Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia. Leuk Res, 24, 971-4. https://doi.org/10.1016/S0145-2126(00)00052-7
  11. Ghanei M, Vosoghi AA (2002). An epidemiologic study to screen for chronic myelocytic leukemia in war victims exposed to mustard gas. Environ Health Perspect, 110, 519-21. https://doi.org/10.1289/ehp.02110519
  12. Hishida A, Terakura S, Emi N, et al 2005 . GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev , 6, 251-5.
  13. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600. https://doi.org/10.3109/10409239509083491
  14. Hallier E, Langhof T, Dannappel D, et al (1993). Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: influence on the induction of sister chromatid exchanges (SCE) in lymphocytes. Arch Toxicol, 67, 173-8. https://doi.org/10.1007/BF01973304
  15. Hishida A, Terakura S, Emi N, et al (2005) .GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev, 6, 251-5.
  16. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993). The CYP1A1 gene and cancer susceptibility. Crit Rev Oncol Hematol, 14, 77-87. https://doi.org/10.1016/1040-8428(93)90007-Q
  17. Lourenco GJ, Ortega MM, Nascimento H, et al (2005). Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta 1 (GSTT1) genes in chronic myeloid leukaemia. Eur J Haematol, 75, 530-1. https://doi.org/10.1111/j.1600-0609.2005.00567.x
  18. Meggyesi N, Kozma A, Halm G, et al (2011). Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients. Acta Haematologica, 127, 34-42. https://doi.org/10.1159/000331472
  19. McLellan RA, Oscarson M, Alexandrie AK, et al (1997). Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol , 52, 958-65. https://doi.org/10.1124/mol.52.6.958
  20. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B (2010). Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer, 62, 734-42. https://doi.org/10.1080/01635581003605904
  21. Mondal BC, Paria N, Majumdar S, et al (2005). Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev, 14, 281-4. https://doi.org/10.1097/00008469-200506000-00014
  22. Quinones L, Lucas D, Godoy J, et al (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett, 174, 35-44. https://doi.org/10.1016/S0304-3835(01)00686-3
  23. Rollinson S, Roddam P, Kane E, et al (2000). Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis, 21, 43-7. https://doi.org/10.1093/carcin/21.1.43
  24. Redaelli A, Bell C, Casagrande J, et al (2004). Clinical and epidemiologic burden of chronic myelogenous leukemia. Expert Rev Anticancer Ther, 4, 85-96. https://doi.org/10.1586/14737140.4.1.85
  25. Rowley JD. (1973). Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 290-3. https://doi.org/10.1038/243290a0
  26. Roy B, Majumder PP, Dey B, et al (2001). Ethnic differences in distributions of GSTM1 and GSTT1 homozygous "null" genotypes in India. Hum Biol, 73, 443-50. https://doi.org/10.1353/hub.2001.0040
  27. Sambrook J, Rusell (2001).Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
  28. Tan W, Song N, Wang GQ, et al (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol. Biomarkers Prev, 9, 551-6.
  29. Weber WW (1999). Populations and genetic polymorphisms. Mol Diagn, 4, 299-307. https://doi.org/10.1016/S1084-8592(99)80006-X
  30. Xu X, Wiencke JK, Niu T, et al (1998). Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am J Ind Med, 33, 157-63. https://doi.org/10.1002/(SICI)1097-0274(199802)33:2<157::AID-AJIM7>3.0.CO;2-V

Cited by

  1. Genetic Polymorphisms of GSTM1 and GSTT1 Genes in Delhi and Comparison with other Indian and Global Populations vol.13, pp.11, 2012, https://doi.org/10.7314/APJCP.2012.13.11.5647
  2. GSTP1 (Ile105Val) Gene Polymorphism: Risk and Treatment Response in Chronic Myeloid Leukemia vol.05, pp.01, 2014, https://doi.org/10.4236/jct.2014.51001
  3. Epidemiological Assessment of Leukemia in Kazakhstan, 2003-2012 vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6969
  4. Genetic Polymorphisms in Chronic Myeloid Leukemia: A Case-Control Study vol.2014, pp.1942-0994, 2014, https://doi.org/10.1155/2014/875861
  5. Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population vol.31, pp.5, 2014, https://doi.org/10.1007/s12032-014-0889-4
  6. Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia vol.35, pp.6, 2014, https://doi.org/10.1007/s13277-014-1810-7
  7. Chronic Myeloid Leukemia - Prognostic Value of Mutations vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7415
  8. Treatment and Survival in Patients with Chronic Myeloid Leukemia in a Chronic Phase in West Iran vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7555
  9. Association of glutathione S-transferase (GSTM1 and GSTT1) genes with chronic myeloid leukemia vol.4, pp.1, 2015, https://doi.org/10.1186/s40064-015-0966-y
  10. CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case–control study vol.15, pp.2, 2016, https://doi.org/10.1007/s10689-015-9849-1
  11. Association between polymorphism of GSTP1, GSTT1, GSTM1 and CYP2E1 genes and susceptibility to benzene-induced hematotoxicity pp.1432-0738, 2018, https://doi.org/10.1007/s00204-017-2104-9
  12. copy number variant in complex disease risks vol.43, pp.3, 2016, https://doi.org/10.3109/03014460.2015.1049206
  13. Genetic Polymorphisms Associated with Environmental Exposure to Polycyclic Derivatives in African Children vol.2018, pp.1875-8630, 2018, https://doi.org/10.1155/2018/9078939
  14. Glutathione S-transferase M1 and T1 null genotype frequency distribution among four tribal populations of western India vol.97, pp.1, 2018, https://doi.org/10.1007/s12041-018-0888-x